CTRI/2022/11/046972
Not yet recruiting
Phase 2
Preclinical and clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of BALAR PAKKA VATHAM ( INFANTILE HEMIPLEGIA)in children.
DR M MUKILA0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: G819- Hemiplegia, unspecified
- Sponsor
- DR M MUKILA
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Stiffness and weekness in muscles on one side of the body
- •Muscle spasm
- •Delayed milestones
- •Difficulty with walking and balance
Exclusion Criteria
- •Children below 2 years
- •Children above 12 years
- •Congenoital cardiac failure
- •Infantile hemiplegia with associated congenital abnormalities
- •Infantile hemiplegia with co\-morbidities like mental retardation and muscular dystrophy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in childreCTRI/2022/01/039863Dr S Surendar
Completed
Phase 2
Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCYHealth Condition 1: E539- Vitamin B deficiency, unspecifiedCTRI/2022/02/039956Dr S Aiswarya40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug GANTHAGA NEI(oral administration) along with NATHTHAICHOORI TAILAM(external therapy) in the management of CEREBRAL PALSY.Health Condition 1: G801- Spastic diplegic cerebral palsyHealth Condition 2: G802- Spastic hemiplegic cerebral palsyCTRI/2022/06/043082Dr P RAJAVATHANA40
Active, not recruiting
Phase 2
Preclinical and clinical evaluation of siddha classical drug MEDATHAARI CHOORANAM (oral administration) and CHITHIRAMOOLA TAILAM (external) in the management of JUVENILE ARTHRITIS.CTRI/2022/01/039856Dr P Ponsridharani
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER (oral administration ) along with PODI THIMIRTHAL ( external therapy) in the management of CHILDHOOD OBESITY.Health Condition 1: E65- Localized adiposityHealth Condition 2: E660- Obesity due to excess caloriesHealth Condition 3: E663- OverweightCTRI/2022/02/040297Dr J Mangalavalli40